🇺🇸 FDA
Pipeline program

retinal pigment epithelium transplantation

ChineseASZQ-004

Phase 2 mab active

Quick answer

retinal pigment epithelium transplantation for Dry Age-related Macular Degeneration is a Phase 2 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Dry Age-related Macular Degeneration
Phase
Phase 2
Modality
mab
Status
active

Clinical trials